In vitro antifungal susceptibility of miltefosine alone and in combination with amphotericin B against emerging multidrug resistant Candida auris.
Candida auris, a globally emerging human fungal pathogen, has arisen as a public health concern worldwide because of its ability to cause nosocomial outbreaks and its resistance to multiple antifungal drugs (1, 2).….